Michael P. Rettig - Concepedia

Author

Michael P. Rettig

Washington University in St. Louis ORCID

Also Known As

Daniel C. Link, M P Rettig, M Rettig, M. Rettig, M.P. Rettig, Michael P Rettig, Michael P. Rettig, Michael Rettig, Michael Rettig (321972), Mike Rettig

318

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis MacroGenics (United States)The University of Texas MD Anderson Cancer Center Emory University Mallinckrodt (United States)

About

Michael P. Rettig is an author at Washington University in St. Louis specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	1K
2	Health Sciences	9	9	536
3	Engineering	2	2	62
4	Biomedical Engineering	1	1	37
5	Biostatistics	1	1	29

Michael P. Rettig

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 Bruno Nervi, Pablo Ramírez, Michael P. Rettig, Blood	2008	477
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation Matthew Christopher, Allegra A. Petti, Michael P. Rettig, New England Journal of Medicine	2018	457
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi, Blood	2012	381
An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies Matthew Cooper, Jaebok Choi, Karl Staser, Leukemia Cell TherapyHematologyImmunologyCell Replacement TherapyImmunotherapy	2018	381
Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation Iskra Pusic, Shi Yuan Jiang, Scott Landua, Biology of Blood and Marrow Transplantation	2008	348
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Blood	2020	307
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction Steven M. Devine, Ravi Vij, Michael P. Rettig, Blood	2008	306
Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis Patrick G. Gallagher, Seon Hee Chang, Michael P. Rettig, Blood	2003	221
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia Jayakumar Vadakekolathu, Mark D. Minden, Tressa Hood, Science Translational Medicine Immune Gene ExpressionMixed-phenotype Acute LeukemiaImmunologyImmune RegulationPredict Chemotherapy Resistance	2020	200
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells Pablo Ramírez, Michael P. Rettig, Geoffrey L. Uy, Blood	2009	174

Page 1